1. Home
  2. WKHS vs HOTH Comparison

WKHS vs HOTH Comparison

Compare WKHS & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

N/A

Current Price

$3.35

Market Cap

17.4M

ML Signal

N/A

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

N/A

Current Price

$1.10

Market Cap

15.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WKHS
HOTH
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
15.8M
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
WKHS
HOTH
Price
$3.35
$1.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$21.00
$5.00
AVG Volume (30 Days)
60.9K
353.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$763,173.00
N/A
Revenue This Year
$81.01
N/A
Revenue Next Year
$34.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.66
52 Week High
$11.80
$2.12

Technical Indicators

Market Signals
Indicator
WKHS
HOTH
Relative Strength Index (RSI) 33.80 58.19
Support Level $3.22 $0.99
Resistance Level $6.00 $1.12
Average True Range (ATR) 0.20 0.06
MACD 0.04 0.01
Stochastic Oscillator 31.48 44.98

Price Performance

Historical Comparison
WKHS
HOTH

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: